Ascentage Pharma Publicly Traded Corporation
Clinical-stage biotechnology company developing targeted therapies for cancer, particularly drugs designed to restore apoptosis in tumor cells.
Investors
.png)
.jpg)
(INV)%20.jpg)
Technology:
Biotech pipeline
Estimated Revenue:
~$50–100M
Founded Date:
2019